Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade

Research output: Contribution to journalReview articlepeer-review

Abstract

Here, we review the most recent findings on the effects of SARS-CoV-2 infection on kidney diseases, including acute kidney injury, and examine the potential effects of ARBs on the outcomes of patients with COVID-19. Lastly, we discuss the clinical management of COVID-19 patients with existing chronic renal disorders, particularly those in dialysis and with kidney transplants.

Original languageEnglish
Pages (from-to)213-221
Number of pages9
JournalNephron
Volume144
Issue number5
DOIs
Publication statusPublished - 2020

Keywords

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme 2
  • Angiotensin-Converting Enzyme Inhibitors
  • Angiotensins/antagonists & inhibitors
  • Betacoronavirus/physiology
  • COVID-19
  • Coronavirus Infections/complications
  • Humans
  • Kidney/virology
  • Kidney Diseases/complications
  • Kidney Transplantation
  • Nephrologists
  • Pandemics
  • Peptidyl-Dipeptidase A
  • Pneumonia, Viral/complications
  • Renal Dialysis
  • SARS-CoV-2
  • Virus Replication

Fingerprint Dive into the research topics of 'Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade'. Together they form a unique fingerprint.

Cite this